Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Oncogene|January 17, 2017
PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanomaJ Delyon, A Servy, F Laugier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2003
Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patientsL Fardet, L Blum, D Kerob, et al.
The British Journal of Dermatology|December 1, 1995
Bacillary angiomatosis in HIV-infected patients: report of three cases with different clinical courses and identification of Rochalimaea quintana as the aetiological agentH Bachelez, E Oksenhendler, C Lebbé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2013
Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trialsJ D Wolchok, J S Weber, M Maio, et al.
Bone Marrow Transplantation|February 3, 2004
High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphomaS Ingen-Housz-Oro, H Bachelez, O Verola, et al.
Annales De Dermatologie Et De Venereologie|July 28, 2007
[Acquired cutis laxa and myeloma: large vacuolated cells in the dermis]G Frémont, D Kérob, C Prost-Squarcioni, et al.
The Journal of Investigative Dermatology|October 26, 2001
Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapyC Pellet, S Chevret, L Blum, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survivalC Francès, A G Marcelin, Ch Legendre, et al.
Annales De Dermatologie Et De Venereologie|November 26, 2019
[Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices]C Orion, M Dinulescu, S Dalac-Rat, et al.
Annales De Dermatologie Et De Venereologie|February 13, 2021
Which adjuvant treatment for patients with BRAF<sup>V600</sup>-mutant cutaneous melanoma?E Funck-Brentano, N Malissen, A Roger, et al.
Pageof 7